MDXG Q4 2023 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+16.7% YoY

Gross Profit

$73M84.1% margin

Operating Income

$15M17.8% margin

Net Income

$53M61.6% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$239M

Total Liabilities

$96M

Stockholders' Equity

$143M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$74M	+16.7%
Gross Profit	$73M	$60M	+21.6%
Operating Income	$15M	$1M	+1351.7%
Net Income	$53M	-$415,000	+12985.8%